CSIMarket Company Name, Ticker, Competitors, else..
 
Imagenebio Inc   (NASDAQ: IMA)
 

Imagenebio Inc's Suppliers Performance

IMA's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
IMA Costs vs Sales of Suppliers Growth

• More on IMA Suppliers






Imagenebio Inc's Comment on Supply Chain


The company currently relies exclusively on Wuxi Biologics for biological development and manufacturing services related to clinical development and potential commercial manufacturing of its product candidates. The company acknowledges the availability of multiple sources for required materials and may engage additional contract development and manufacturing organizations (CDMOs) in the future. CDMOs are responsible for chemistry, manufacturing, and controls activities, including process development, analytical method qualification, and production under current Good Manufacturing Practices (cGMP) for clinical trials. The company qualifies and oversees CDMOs through technical and quality assurance reviews, quality agreements, and on-site observations. It anticipates entering longer-term commercial supply agreements as product candidates progress.

Imagenebio Inc's Comment on Supply Chain


The company currently relies exclusively on Wuxi Biologics for biological development and manufacturing services related to clinical development and potential commercial manufacturing of its product candidates. The company acknowledges the availability of multiple sources for required materials and may engage additional contract development and manufacturing organizations (CDMOs) in the future. CDMOs are responsible for chemistry, manufacturing, and controls activities, including process development, analytical method qualification, and production under current Good Manufacturing Practices (cGMP) for clinical trials. The company qualifies and oversees CDMOs through technical and quality assurance reviews, quality agreements, and on-site observations. It anticipates entering longer-term commercial supply agreements as product candidates progress.







IMA's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Imagenebio Inc 79.03 0.00 -54.76 15
SUBTOTAL 0.00 0.00 0.00 -


Sources: Imagenebio Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Imagenebio Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.